Genome & Company (KOSDAQ:314130)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,845.00
+135.00 (4.98%)
At close: Oct 10, 2025

Genome & Company Revenue

Genome & Company had revenue of 5.81B KRW in the quarter ending June 30, 2025, a decrease of -50.04%. This brings the company's revenue in the last twelve months to 24.02B, up 0.39% year-over-year. In the year 2024, Genome & Company had annual revenue of 27.74B with 94.07% growth.

Revenue (ttm)
24.02B
Revenue Growth
+0.39%
P/S Ratio
3.68
Revenue / Employee
n/a
Employees
n/a
Market Cap
88.44B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202427.74B13.45B94.07%
Dec 31, 202314.30B211.39M1.50%
Dec 31, 202214.08B13.63B3,021.27%
Dec 31, 2021451.25M300.66M199.67%
Dec 31, 2020150.58M104.75M228.54%
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition